Biotech Values

[DewDiligence]

MNTA/BIIB—I remember reading a posting on this board mentioning Biogen Idec as an ideal partner/buyout candidate.

You may be thinking of the article in #msg-57560634, which talks about BIIB’s interest in FoB’s.

In any case, we can surmise that a near-term deal between MNTA and BIIB is highly unlikely; if such a deal were under discussion, Dr. Kwon would presumably have remained at BIIB until it had been consummated.